SCHEMBL5223775

SCHEMBL5223775

COC(=O)c1cc(N)cc(N2CCCS2(=O)=O)c1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.39
NPC1 O15118 3/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
PIK3C3 Q8NEB9 2/20 0.39
CTSD P07339 2/20 0.36
BACE1 P56817 2/20 0.36
BACE2 Q9Y5Z0 2/20 0.36
TP53 P04637 6/20 0.36
ALOX5AP P20292 2/20 0.35
FEN1 P39748 2/20 0.35
OPRK1 P41145 1/20 0.35
ALDH1A1 P00352 2/20 0.34
MAPT P10636 2/20 0.34
HPGD P15428 2/20 0.34
GAA P10253 2/20 0.34
GLA P06280 1/20 0.34
CASP1 P29466 1/20 0.34
CASP7 P55210 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5223229 0.96 KDM4E (0.41) KDM4ENPC1RAB9ASMN1; SMN2NPSR1
SCHEMBL5226784 0.85 PIK3C3 (0.39) KDM4ENPC1RAB9ASMN1; SMN2NPSR1
SCHEMBL5223226 0.84 KDM4E (0.38) KDM4ENPC1RAB9ASMN1; SMN2NPSR1
SCHEMBL5224667 0.82 PIK3C3 (0.37) KDM4ENPC1RAB9ASMN1; SMN2NPSR1
SCHEMBL5224665 0.82 PIK3C3 (0.37) KDM4ENPC1RAB9ASMN1; SMN2NPSR1
SCHEMBL5222772 0.82 KDM4E (0.41) KDM4ENPC1RAB9ASMN1; SMN2NPSR1
SCHEMBL5217755 0.82 CTSD (0.37) KDM4ENPC1RAB9ASMN1; SMN2NPSR1
SCHEMBL5221011 0.81 CTSD (0.39) SMN1; SMN2PIK3C3CTSDBACE1BACE2
SCHEMBL5221774 0.81 BACE1 (0.49) SMN1; SMN2PIK3C3CTSDBACE1BACE2
SCHEMBL5218540 0.81 ALDH1A1 (0.43) KDM4ENPC1SMN1; SMN2PIK3C3OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-B1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LTD (GB) 2007-02-21 EP disclosed